Ceylon Tobacco Company Earnings Call Transcripts
Fiscal Year 2026
-
Q1 2026 saw a net loss of $7.7M, mainly due to non-cash digital asset losses, as the company transitioned to AI compute services. A $260M, 36-month contract will drive $21M in quarterly revenue starting Q3 2026, with a $4.3B pipeline supporting strong growth expectations.
Fiscal Year 2025
-
Secured $12M in new contracts and expanded enterprise deployments, with a strategic shift to AI compute services and a $43M compute reserve. Fiscal 2025 saw a net loss driven by non-cash digital asset revaluations, but strong liquidity and pipeline growth position the company for 2026.
-
Q3 2025 saw a major strategic shift with the launch of a digital asset treasury focused on Aethir's ATH token, driving new revenue streams and positioning for AI infrastructure growth. Financials were impacted by non-cash charges, but operational cash burn declined and a robust pipeline is developing.
Fiscal Year 2024
-
Q2 2024 saw expanded AI-driven biomarker discovery, a new 3D cell culture launch, and a University of Michigan drug discovery partnership. Revenues declined year-over-year, but cost reductions and capital raises improved the financial outlook.